Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 9,098 | 10,486 | 7,600 | 185 |
| Gross Profit | 9,098 | 10,486 | 7,600 | 185 |
| Operating Expenses | 74,864 | 38,676 | 21,603 | 21,611 |
| Operating Income | -65,766 | -28,190 | -14,003 | -21,426 |
| Interest Expense | 1,017 | 1,719 | 1,021 | 161 |
| Other Income | 41 | 273 | -63 | 23 |
| Pre-tax Income | -66,742 | -29,636 | -15,087 | -21,564 |
| Net Income Continuous | -66,742 | -29,636 | -15,087 | -21,564 |
| Net Income | $-66,742 | $-29,636 | $-15,087 | $-21,564 |
| EPS Basic Total Ops | -49.80 | -35.60 | -950.80 | -1,466.80 |
| EPS Basic Continuous Ops | -49.79 | -35.57 | -951.86 | -1,466.94 |
| EPS Diluted Total Ops | -49.80 | -35.60 | -950.80 | -1,466.80 |
| EPS Diluted Continuous Ops | -49.79 | -35.57 | -951.86 | -1,466.94 |
| EPS Diluted Before Non-Recurring Items | -49.80 | N/A | N/A | N/A |
| EBITDA(a) | $-65,416 | $-27,719 | $-13,475 | $-20,827 |